{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:20:09Z","timestamp":1775755209585,"version":"3.50.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Islet transplantation in type 1 diabetes mellitus restores endogenous insulin secretion and hypoglycemia awareness. Although high-quality prospective clinical trials have demonstrated the efficacy of islet transplantation, reports on the clinical outcomes in Asia remain scarce. Therefore, we conducted a clinical trial in Japan to verify the effectiveness of islet transplantation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>This multicenter, single-arm study aimed to evaluate the clinical efficacy and safety of immunosuppressive therapy for allogeneic islet transplantation. The immunosuppressive regimens included antithymocyte globulin, calcineurin inhibitors, and mycophenolate mofetil. The primary endpoint was a glycated hemoglobin level of &lt;7.4% on day 365 and the absence of severe hypoglycemic events from 1 mo to 1 y after the first transplantation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Eight recipients with evaluation data obtained 1 y after the initial transplantation were included in the efficacy analysis. Of the 8 recipients, 3, 3, and 2 recipients received 1, 2, and 3 islet infusions, respectively. Six recipients (75%) achieved the primary endpoint. The median glycated hemoglobin levels declined from an initial 7.3% to 6.3% and 6.1% on days 375 and 730, respectively, with related improvements in hypoglycemia awareness and glucose variability. No complications associated with intraportal transplantation, such as intraperitoneal hemorrhage or portal vein embolism, were observed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Islet transplantation provided near-normal glycemic control and protection against severe hypoglycemic events in patients with type 1 diabetes mellitus in this Japanese cohort. Future studies are needed to confirm whether long-term graft survival can be achieved and whether it is possible to prevent the progression of diabetic complications.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001765","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T20:01:03Z","timestamp":1738958463000},"page":"e1765","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and Safety of Allogeneic Islet Transplantation Demonstrated by a Multicenter Clinical Trial in Japan"],"prefix":"10.1097","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7625-5750","authenticated-orcid":false,"given":"Takayuki","family":"Anazawa","sequence":"first","affiliation":[{"name":"Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Marubashi","sequence":"additional","affiliation":[{"name":"Department of Hepato-Biliary-Pancreatic and Transplant Surgery, Fukushima Medical University, Fukushima, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohta","family":"Kodama","sequence":"additional","affiliation":[{"name":"Department of Regenerative Medicine and Transplantation, Fukuoka University, Fukuoka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Goto","sequence":"additional","affiliation":[{"name":"Division of Transplantation and Regenerative Medicine, Tohoku University, Sendai, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Eguchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Shimoda","sequence":"additional","affiliation":[{"name":"Department of Pancreatic Islet Cell Transplantation, National Center for Global Health and Medicine Research Institute, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Regenerative Medicine, Graduate School of Medicine, University of the Ryukyus, Ginowan, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuhiro","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Graduate School of Medicine, Tohoku University, Sendai, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taihei","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Transplantation and Regenerative Medicine, Fujita Medical University, Toyoake, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kenmochi","sequence":"additional","affiliation":[{"name":"Department of Transplantation and Regenerative Medicine, Fujita Medical University, Toyoake, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsukazu","family":"Gotoh","sequence":"additional","affiliation":[{"name":"Osaka General Medical Center, Osaka, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"R1-20250207","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","article-title":"Epidemiology of type 1 diabetes.","volume":"39","author":"Maahs","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R2-20250207","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.2337\/db14-0059","article-title":"Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia.","volume":"63","author":"Cryer","year":"2014","journal-title":"Diabetes"},{"key":"R3-20250207","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ags3.12214","article-title":"Current state and future evolution of pancreatic islet transplantation.","volume":"3","author":"Anazawa","year":"2019","journal-title":"Ann Gastroenterol Surg"},{"key":"R4-20250207","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2337\/dc15-1988","article-title":"Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia.","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care"},{"key":"R5-20250207","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/ajt.16174","article-title":"Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes.","volume":"21","author":"Markmann","year":"2021","journal-title":"Am J Transplant"},{"key":"R6-20250207","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/ajt.12250","article-title":"Multicenter Australian trial of islet transplantation: improving accessibility and outcomes.","volume":"13","author":"O\u2019Connell","year":"2013","journal-title":"Am J Transplant"},{"key":"R7-20250207","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S2213-8587(18)30078-0","article-title":"Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial.","volume":"6","author":"Lablanche","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R8-20250207","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41588-018-0332-4","article-title":"Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population.","volume":"51","author":"Suzuki","year":"2019","journal-title":"Nat Genet"},{"key":"R9-20250207","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/TP.0b013e3181ecb044","article-title":"Islet transplantation using donors after cardiac death: report of the Japan Islet Transplantation Registry.","volume":"90","author":"Saito","year":"2010","journal-title":"Transplantation"},{"key":"R10-20250207","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.transproceed.2014.06.006","article-title":"Long-term outcomes of clinical transplantation of pancreatic islets with uncontrolled donors after cardiac death: a multicenter experience in Japan.","volume":"46","author":"Anazawa","year":"2014","journal-title":"Transplant Proc"},{"key":"R11-20250207","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/diacare.18.4.517","article-title":"Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms.","volume":"18","author":"Clarke","year":"1995","journal-title":"Diabetes Care"},{"key":"R12-20250207","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2337\/diabetes.53.4.955","article-title":"Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation.","volume":"53","author":"Ryan","year":"2004","journal-title":"Diabetes"},{"key":"R13-20250207","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2337\/diacare.28.2.343","article-title":"Beta-score: an assessment of beta-cell function after islet transplantation.","volume":"28","author":"Ryan","year":"2005","journal-title":"Diabetes Care"},{"key":"R14-20250207","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00007890-200407271-00941","article-title":"Influence of pancreas preservation on human islet isolation outcomes: impact of the two-layer method.","volume":"78","author":"Tsujimura","year":"2004","journal-title":"Transplantation"},{"key":"R15-20250207","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/01.tp.0000231710.37981.64","article-title":"Successful islet transplantation from nonheartbeating donor pancreata using modified Ricordi islet isolation method.","volume":"82","author":"Matsumoto","year":"2006","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"R16-20250207","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/diab.38.1.S140","article-title":"Automated islet isolation from human pancreas.","volume":"38","author":"Ricordi","year":"1989","journal-title":"Diabetes"},{"key":"R17-20250207","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"R18-20250207","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jval.2013.06.022","article-title":"Benchmarks for interpretation of score differences on the SF-36 health survey for patients with diabetes.","volume":"16","author":"Bjorner","year":"2013","journal-title":"Value Health"},{"key":"R20-20250207","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2337\/dc17-1779","article-title":"Improved health-related quality of life in a phase 3 islet transplantation trial in type 1 diabetes complicated by severe hypoglycemia.","volume":"41","author":"Foster","year":"2018","journal-title":"Diabetes Care"},{"key":"R21-20250207","doi-asserted-by":"crossref","first-page":"10507","DOI":"10.3389\/ti.2022.10507","article-title":"A worldwide survey of activities and practices in clinical islet of Langerhans transplantation.","volume":"35","author":"Berney","year":"2022","journal-title":"Transpl Int"},{"key":"R22-20250207","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00125-022-05804-4","article-title":"Factors associated with favourable 5 year outcomes in islet transplant alone recipients with type 1 diabetes complicated by severe hypoglycaemia in the Collaborative Islet Transplant Registry.","volume":"66","author":"Hering","year":"2023","journal-title":"Diabetologia"},{"key":"R23-20250207","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1111\/ajt.16533","article-title":"Clinical use of donation after circulatory death pancreas for islet transplantation.","volume":"21","author":"Doppenberg","year":"2021","journal-title":"Am J Transplant"},{"key":"R24-20250207","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3390\/jcm8091430","article-title":"The effects of using pancreases obtained from brain-dead donors for clinical islet transplantation in Japan.","volume":"8","author":"Ito","year":"2019","journal-title":"J Clin Med"},{"key":"R25-20250207","first-page":"41","article-title":"The guidelines for percutaneous transhepatic portal vein embolization: English version.","volume":"9","author":"Hashimoto","year":"2024","journal-title":"Interv Radiol (Higashimatsuyama)"},{"key":"R26-20250207","doi-asserted-by":"crossref","first-page":"e013434","DOI":"10.1136\/bmjopen-2016-013434","article-title":"Randomised, prospective, medico-economic nationwide French study of islet transplantation in patients with severely unstable type 1 diabetes: the STABILOT study protocol.","volume":"7","author":"Lablanche","year":"2017","journal-title":"BMJ Open"},{"key":"R27-20250207","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2337\/dc12-0063","article-title":"Improvement in outcomes of clinical islet transplantation: 1999-2010.","volume":"35","author":"Barton","year":"2012","journal-title":"Diabetes Care"},{"key":"R28-20250207","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.2337\/dc21-2688","article-title":"Long-term outcomes with islet-alone and islet-after-kidney transplantation for type 1 diabetes in the clinical islet transplantation consortium: the CIT-08 study.","volume":"45","author":"Rickels","year":"2022","journal-title":"Diabetes Care"},{"key":"R29-20250207","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S2213-8587(22)00114-0","article-title":"Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada.","volume":"10","author":"Marfil-Garza","year":"2022","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T20:01:13Z","timestamp":1738958473000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001765","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]}}}